The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
Open accessAbstract
Myotonic dystrophy type 1 (DM1) is caused by toxicity of an expanded, noncoding (CUG)n tract in DM protein kinase (DMPK) transcripts. According to current evidence the long (CUG)n segment is involved in entrapment of muscleblind (Mbnl) proteins in ribonuclear aggregates and stabilized expression of CUG binding protein 1 (CUGBP1), causing aberrant premRNA splicing and associated pathogenesis in DM1 patients. Here, we report on the use of antisense oligonucleotides (AONs) in a therapeutic strategy for reversal of RNA-gain-of-function toxicity. Using a previously undescribed mouse DM1 myoblast−myotube cell model and DM1 patient cells as screening tools, we have identified a fully 2′-O-methyl-phosphorothioate-modified (CAG)7 AON that silences mutant DMPK RNA expression and reduces the number of ribonuclear aggregates in a selective and (CUG)n-length-dependent manner. Direct administration of this AON in muscle of DM1 mouse models in vivo caused a significant reduction in the level of toxic (CUG)n RNA and a normalizing effect on aberrant premRNA splicing. Our data demonstrate proof of principle for therapeutic use of simple sequence AONs in DM1 and potentially other unstable microsatellite diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Antisense technologies: Improvement through novel chemical modifications
Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,006
Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Local Dystrophin Restoration with Antisense Oligonucleotide PRO051
van Deutekom, J. C., Janson, A. A., Ginjaar, I. B., Frankhuizen, W. S., Aartsma-Rus, A., Bremmer-Bout, M., den Dunnen, J. T., Koop, K., van der Kooi, A. J., Goemans, N. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073108 · Cited by 781
Self-citationMyotonic Dystrophy in Transgenic Mice Expressing an Expanded CUG Repeat
Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M., & Thornton, C. A. (2000) · Science · doi:10.1126/science.289.5485.1769 · Cited by 737
Self-citationFoci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.
Taneja, K. L., McCurrach, M., Schalling, M., Housman, D., & Singer, R. H. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.6.995 · Cited by 599
Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy
Lin, X., Miller, J. W., Mankodi, A., Kanadia, R. N., Yuan, Y., Moxley, R. T., Swanson, M. S., & Thornton, C. A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl132 · Cited by 510 · cited 1×
“Many embryonic splice modes in skeletal muscle observed in DM1 patients are replicated in HSALR mice (16)—in contrast to DM500 mice, which display hardly any DM1-typical splice modes in skeletal muscle and also RNP foci much less overtly (21).”
BackgroundSelf-citationSpecificity, duplex degradation and subcellular localization of antagomirs
Krützfeldt, J., Kuwajima, S., Braich, R., Rajeev, K. G., Pena, J., Tuschl, T., Manoharan, M., & Stoffel, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm024 · Cited by 455
Kuyumcu-Martinez, N. M., Wang, G.-S., & Cooper, T. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.027 · Cited by 445
Kanadia, R. N., Shin, J., Yuan, Y., Beattie, S. G., Wheeler, T. M., Thornton, C. A., & Swanson, M. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604970103 · Cited by 371
Self-citationRNA Quality Control in Eukaryotes
Doma, M. K., & Parker, R. (2007) · Cell · doi:10.1016/j.cell.2007.10.041 · Cited by 345
Wheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. T., & Thornton, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33355 · Cited by 256
Self-citationKrol, J., Fiszer, A., Mykowska, A., Sobczak, K., de Mezer, M., & Krzyzosiak, W. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.031 · Cited by 196
Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy
Mahadevan, M. S., Yadava, R. S., Yu, Q., Balijepalli, S., Frenzel-McCardell, C. D., Bourne, T. D., & Phillips, L. H. (2006) · Nature Genetics · doi:10.1038/ng1857 · Cited by 185
Myotonic dystrophy: RNA-mediated muscle disease
Wheeler, T. M., & Thornton, C. A. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282ef6064 · Cited by 181
Self-citationSeznec, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1185 · Cited by 165
Langlois, M., Boniface, C., Wang, G., Alluin, J. V., Salvaterra, P. M., Puymirat, J., Rossi, J. J., & Lee, N. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501591200 · Cited by 146
Holen, T., Amarzguioui, M., Babaie, E., & Prydz, H. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg338 · Cited by 123
Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts
Langlois, M., Lee, N. S., Rossi, J. J., & Puymirat, J. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00068-6 · Cited by 104
Furling, D., Lemieux, D., Taneja, K. L., & Puymirat, J. (2001) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00226-7 · Cited by 100
Self-citationLorenz, P. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.2.582 · Cited by 94
Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions
Furling, D., Doucet, G., Langlois, M., Timchenko, L., Belanger, E., Cossette, L. J., & Puymirat, J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301955 · Cited by 81
Self-citationTiscórnia, G., & Mahadevan, M. S. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80261-0 · Cited by 73
Goodman, A. B. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560130 · Cited by 67
DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice
Guiraud-Dogan, C., Huguet-Lachon, A., Gomes-Pereira, M., Brisson, E., Bassez, G., Junien, C., & Gourdon, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.08.004 · Cited by 56
Self-citationCirugía carotídea bajo anestesia regional
Gutiérrez-Baz, M., Luján-Huertas, S., Perera-Sabio, M., Cáncer-Pérez, S., & Puras-Mallagray, E. (2004) · Angiología · doi:10.1016/s0003-3170(04)74856-7 · Cited by 31
Cited by
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Non-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,032
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Rinaldi, C., & Wood, M. J. A. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.148 · Cited by 788
Targeting nuclear RNA for in vivo correction of myotonic dystrophy
Wheeler, T. M., Leger, A. J., Pandey, S. K., MacLeod, A. R., Nakamori, M., Cheng, S. H., Wentworth, B. M., Bennett, C. F., & Thornton, C. A. (2012) · Nature · doi:10.1038/nature11362 · Cited by 502
Self-citation
Metadata
- Authors
- Mulders, S. A. M., van den Broek, W. J. A. A., Wheeler, T. M., Croes, H. J. E., van Kuik-Romeijn, P., de Kimpe, S. J., Furling, D., Platenburg, G. J., Gourdon, G., Thornton, C. A., Wieringa, B., & Wansink, D. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-08-18
- Volume
- 106
- Issue
- 33
- Pages
- 13915-13920
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1972453061
- Cited by
- 257
- References
- 26
- FWCI
- 9.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.